New: NCI-funded clinical trial search
Mednet Logo

What do you quote as the recurrence risk without radiation for patients that undergo neoadjuvant systemic therapy followed by lumpectomy and are found to have a complete pathologic response?

Patients will frequently ask why they need treatment when there is no cancer left on the pathology specimen.
1 Answer
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Varian Medical Systems/Allegheny health network
Answered on

We don’t have any data to quote and this is still an unanswered question.

Rather, there is an interesting phase 2 study omitting surgery in these, it’s showing excellent outcomes.

Kuerer et al., PMID 36306810

Join for free or sign in to see the full answer